Palvella Therapeutics PVLA Insider Ownership

NASDAQ PVLA

$166.02 -8.06 (-4.63%)

As of: Nov 10, 2026 · 1:22 PM EST

Insider Holdings by Owner

365.36K Shares

Capital Management, Llc Adar1144.64K39.6%

George M Jenkins132.62K36.3%

Elaine J Heron47.81K13.1%

Partners L P/Il Bvf38.96K10.7%

Matthew E Korenberg1.00K0.3%

Other insiders (2)3250.1%

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

1.82%

▼-1.20% pp QoQ

Shares Held by Insiders

261.66K

filed for Sep 2026

▼-39.68% QoQ

Shares Outstanding

14.40Mn

14,395,705 shares

Direct Holdings

248.14K

Indirect: 13.52K

Net Open-Market Trades

-40.72K

net sold · -$6.17Mn in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Open-Market Insider Trades

Bought Sold

Latest quarter —

Net over range —

Net-buying quarters —

Insider Ownership Summary

Updated Oct 24, 2026

Over the past year, PVLA insiders bought $849,974 of stock (6.84K shares) and sold $13.84 million (106.95K shares) on the open market.

Counted by insider, open-market buying of PVLA stock in the past 12 months came from 2 insiders and selling from 3 insiders.
Among Palvella Therapeutics' insiders, George M. Jenkins (Director) was the largest open-market buyer over the past 12 months, purchasing $549,974 of stock (4.45K shares), most recently on March 30, 2026.
Meanwhile, the largest open-market sales of PVLA in the past 12 months were by George M. Jenkins (Director), totaling $7.75 million (55K shares), most recently on October 14, 2026.
Palvella Therapeutics' latest insider trade on the open market was a sale of 4.31K shares for $537,307 by Kathleen Goin (Chief Operating Officer) on October 21, 2026.
In transactions other than open-market trades, Palvella Therapeutics insiders acquired 52.95K shares through option exercises and conversions over the past 12 months.
Business Quant data puts insider holdings in PVLA at 234.16K shares across insiders' latest Form 4 filings.
Palvella Therapeutics insiders hold 220.64K shares directly (94.23% of their total) and 13.52K shares (5.77%) indirectly, through entities such as trusts and partnerships.
Business Quant counts 5 insiders with holdings in Palvella Therapeutics stock, among the officers, directors and 10% owners who have filed a Form 4 in the past two years.
PVLA's largest insider holders by reported holdings are George M. Jenkins (Director, 146.13K shares), Elaine J. Heron (Director, 47.81K shares) and BVF Partners L.P. (38.96K shares).
George M. Jenkins holds 62.41% of the combined insider position in Palvella Therapeutics.
Institutional holders reported 97.83% of Palvella Therapeutics' outstanding shares for Q2 2026; insiders' latest Form 4 filings put their stake at about 1.63%, and other investors, including the public, hold the remaining 0.54%.
Over the past 12 months, 12 insiders reported transactions in Palvella Therapeutics stock in 32 Form 4 filings.
Insider figures for PVLA include Form 4 filings through October 23, 2026.

Form 4 Holdings

Insiders Holding PVLA

Insiders 7

Shares held 365.36K

Of outstanding 2.54%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Capital Management, Llc Adar1	TenPercentOwner	0	144,641	144,641	39.6%	12 Aug, 2024
2	George M Jenkins	Director	132,616	0	132,616	36.3%	14 Oct, 2026
3	Elaine J Heron	Director	47,812	0	47,812	13.1%	02 Mar, 2026
4	Partners L P/Il Bvf	Other	38,961	0	38,961	10.7%	17 Dec, 2024
5	Matthew E Korenberg	Cfo, Treasurer	1,000	0	1,000	0.3%	16 Jun, 2026
6	Christopher P Kiritsy	Director	250	0	250	0.1%	04 Sep, 2026
7	Tim Demuth	Chief Medical Officer	75	0	75	0.0%	16 May, 2022

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

402 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
21 Oct, 2026	Kathleen Goin	Chief Operating Officer	Acquired M	2,165	$7.14	$15.46K	2,165	Direct
21 Oct, 2026	Kathleen Goin	Chief Operating Officer	Acquired M	2,148	$9.08	$19.50K	4,313	Direct
21 Oct, 2026	Kathleen Goin	Chief Operating Officer	Disposed S	2,043	$123.62	$252.56K	2,270	Direct
21 Oct, 2026	Kathleen Goin	Chief Operating Officer	Disposed S	1,663	$125.16	$208.15K	607	Direct
21 Oct, 2026	Kathleen Goin	Chief Operating Officer	Disposed S	607	$126.19	$76.60K	0	Direct
21 Oct, 2026	Kathleen Goin	Chief Operating Officer	Disposed M	2,165	$0.00	$0	0	Direct
21 Oct, 2026	Kathleen Goin	Chief Operating Officer	Disposed M	2,148	$0.00	$0	0	Direct
12 Oct, 2026	George M Jenkins	Director	Disposed S	5,095	$132.62	$675.68K	155,021	Direct
12 Oct, 2026	George M Jenkins	Director	Disposed S	2,458	$133.25	$327.52K	152,563	Direct
12 Oct, 2026	George M Jenkins	Director	Disposed S	3,335	$134.21	$447.59K	149,228	Direct
12 Oct, 2026	George M Jenkins	Director	Disposed S	1,447	$135.50	$196.06K	147,781	Direct
12 Oct, 2026	George M Jenkins	Director	Disposed S	817	$136.44	$111.48K	146,964	Direct
13 Oct, 2026	George M Jenkins	Director	Disposed S	2,004	$128.52	$257.56K	144,960	Direct
13 Oct, 2026	George M Jenkins	Director	Disposed S	1,644	$129.23	$212.45K	143,316	Direct
13 Oct, 2026	George M Jenkins	Director	Disposed S	990	$130.48	$129.18K	142,326	Direct
13 Oct, 2026	George M Jenkins	Director	Disposed S	1,035	$131.49	$136.09K	141,291	Direct
13 Oct, 2026	George M Jenkins	Director	Disposed S	579	$132.40	$76.66K	140,712	Direct
13 Oct, 2026	George M Jenkins	Director	Disposed S	922	$133.72	$123.29K	139,790	Direct
14 Oct, 2026	George M Jenkins	Director	Disposed S	476	$121.14	$57.66K	139,314	Direct
14 Oct, 2026	George M Jenkins	Director	Disposed S	2,072	$122.62	$254.06K	137,242	Direct

Showing 1 to 20 of 402 transactions